Tiffany, Kors to Re...
Health Care: Drugs
K-V Pharmaceutical Company (KV.A: NYSE)
$0.32 0.02 | 6.70%
08/03/12 - 03:59 PM ET
291.13K / 927.20K
Vol / Avg. Vol:0.31 / 0.30
Open / Prev. Close:0.29 - 0.32
Today's Range:0.25 - 3.01
52 Wk Range:-77.14%
Performance YTD:TheStreet Rating:
Portfolios with KV.A
- Portfolio NameUser Type
- ContributorStocks Under-$10 Setting Up...
- Contributor10 Most Shorted Stocks in B...
- Userjaspy15 Portfolio 1
- UserMG-Speculation
- Userdabower774
Latest KV.A Headlines from TheStreet
- K-V Stock Falls On Unusually High Volume (KV.A) 02.10.12 | 03:02 pm
- The 5 Dumbest Things on Wall Street: First Quarter 04.01.11 | 06:04 am
- K-V Stock Falls On Unusually High Volume (KV.A) 03.30.11 | 11:03 am
- Dumbest of This Week's 5 Dumbest: KV Pharmaceutical Goes Price Hiking 03.19.11 | 09:03 am
- The 5 Dumbest Things on Wall Street: March 18 03.18.11 | 06:03 am
- Tricks of the Trade for 150% Returns 03.17.11 | 10:03 am
- K-V Stock Falls On Unusually High Volume (KV.A) 02.22.11 | 04:02 pm
- Strategic Diagnostics: Small-Cap Winner 01.12.11 | 12:01 pm
- TSC Ratings' Updates: KV Pharmaceutical 09.29.08 | 05:09 pm
- AstraZeneca Loses U.S. Patent Case 01.18.06 | 09:01 am
Press Releases for KV.A
- Ther-Rx Corporation And Perrigo Company Announce The Availability Of Gynazole-1® (Butoconazole Nitrate Vaginal Cream USP, 2%) For Prescribing - PR Newswire 01.24.13 | 08:01 am
- K-V Pharmaceutical Receives Court Approval Of Hologic Settlement - PR Newswire 12.28.12 | 12:12 pm
- K-V Pharmaceutical Secures Commitment For $85 Million Loan, Reaches Agreement With Senior Noteholders On Principal Terms Of Plan Of Reorganization - PR Newswire 12.12.12 | 06:12 pm
- K-V Pharmaceutical Use Of Cash Collateral Approved By U. S. Bankruptcy Court - PR Newswire 08.10.12 | 08:08 am
- K-V Pharmaceutical "First Day" Motions Approved By U.S. Bankruptcy Court - PR Newswire 08.08.12 | 11:08 am
- K-V Pharmaceutical Class A And Class B Common Stock Begin Trading On The OTC Markets - PR Newswire 08.07.12 | 12:08 pm
- K-V Pharmaceutical Announces Planned Transition Of Trading Of Class A And Class B Common Shares To The OTC Markets - PR Newswire 08.06.12 | 07:08 am
- K-V Pharmaceutical Company Files Voluntary Petitions For Reorganization To Restructure Financial Obligations - PR Newswire 08.04.12 | 12:08 am
- K-V Pharmaceutical Company Announces Additional Notification From NYSE Regarding Listing Criteria - PR Newswire 07.20.12 | 04:07 pm
- K-V Pharmaceutical Company Announces Notification From NYSE Regarding Listing Criteria - PR Newswire 06.29.12 | 06:06 pm
Partner Headlines for KV.A
- Healthcare Biz Review: Sequenom DENIED Injunction, Qiagen WINS FDA Approval - Wall St. Cheat Sheet 07.07.12 | 12:07 pm
- Benzinga's Microcap Movers for Friday May 25, 2012 - Benzinga 05.27.12 | 12:05 pm
- KV Pharmaceuticals Facing Difficulty Overcoming Negative Sentiment Even With A New FDA Investigation - Seeking Alpha 11.17.11 | 08:11 am
- UPDATE: K-V Pharmaceutical Announces Independent Laboratory Testing Demonstrates Important Quality Differences Between FDA-Approved Makena and Compounded 17P Formulations - Benzinga 11.08.11 | 04:11 pm
- Will the Next Apple or Google Be Found Among These Micro Caps? - Seeking Alpha 08.18.11 | 09:08 am
- Beach Point Capital's Favorite Stock Picks - Seeking Alpha 06.22.11 | 09:06 am
- KV Pharmaceutical Overvalued? - Seeking Alpha 02.08.11 | 08:02 am
- Russell 2000's Most Attractive Stocks - SeekingAlpha.com 04.26.10 | 12:04 pm
- Drug Pipeline Pulse Check: Teva on a Tear - SeekingAlpha.com 04.06.10 | 03:04 pm
